Legault Pierre
SEC insider (Form 3/4/5 filer). CIK 0001391045. Director at Syndax Pharmaceuticals Inc (SNDX) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 4, 2026. Located in NEW YORK, NY.
Companies Legault Pierre has filed insider reports for
- Syndax Pharmaceuticals Inc (SNDX): Director
- BICYCLE THERAPEUTICS PLC (BCYC): Director
Legault Pierre
CIK: 0001391045
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
